SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-064333
Filing Date
2024-05-22
Accepted
2024-05-22 17:10:12
Documents
14
Period of Report
2024-05-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2415300d1_8k.htm   iXBRL 8-K 47471
2 EXHIBIT 10.1 tm2415300d1_ex10-1.htm EX-10.1 149041
  Complete submission text file 0001104659-24-064333.txt   404194

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20240517.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20240517_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20240517_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2415300d1_8k_htm.xml XML 3665
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

IRS No.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 24974272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)